Engineered immunity

Developing next-generation immunotherapies that precisely leverage the immune system of each patient.

About Anocca

An innovative therapeutic biotechnology company with unique expertise, technologies and capabilities.

Technology Platform

A technology platform that deploys highly engineered human cellular, genetic and molecular tools to rapidly and accurately interrogate the adaptive immune system so as to develop and manufacture T-cell therapies and reagents.


An advancing preclinical T-Cell Receptor (TCR) asset pipeline with multiple novel therapies and reagents for the treatment of cancer and infectious disease.